Pharmaceutical development of novel lactate-based 6-fluoro-l-DOPA formulations.
Denora N, Lopedota A, de Candia M, Cellamare S, Degennaro L, Luisi R, Mele A, Tricarico D, Cutrignelli A, Laquintana V, Altomare CD, Franco M, Dimiccoli V, Tolomeo A, Scilimati A.
Denora N, et al.
Eur J Pharm Sci. 2017 Mar 1;99:361-368. doi: 10.1016/j.ejps.2016.10.001. Epub 2016 Oct 4.
Eur J Pharm Sci. 2017.
PMID: 27717874